| ²é¿´: 5386 | »Ø¸´: 113 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
ICHQ7(ÖÐÓ¢ÎÄ) ÎÞÖØ¸´
|
||
|
GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 10 November 2000, this guideline is recommended for adoption to the three regulatory parties to ICH[ À´×Ô¿ÆÑмÒ×å Ò©Îﻯѧ¼Ò×å ] |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ICHQ7(ÖÐÓ¢ÎÄ).docx
2012-10-22 13:03:13, 198.41 K
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
260Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ç󲩵¼£üÉúÎïÖÊ»ù¶à¿×̼/³¬¼¶µçÈÝ·½Ïò£¬ÒÑÓÐÏà¹Ø³É¹û£¬Ñ°ÄÜÔ´²ÄÁÏ/̼²ÄÁÏ·½ÏòÀÏʦ
ÒѾÓÐ3È˻ظ´
¶þ±½¼×ͪËáÀàÑÜÉúÎï
ÒѾÓÐ6È˻ظ´
½ÓÊÜÈκε÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸Öпƴó²ÄÁÏÓ뻯¹¤£¬353·Ö»¹Óе÷¼ÁѧУÂð
ÒѾÓÐ12È˻ظ´
320Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
295·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
95Â¥2017-05-08 01:05:35
¼òµ¥»Ø¸´
sjshvdc3Â¥
2012-10-23 00:34
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-10-29 19:43
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
ÆÕͨli5Â¥
2012-11-05 11:05
»Ø¸´
ÈýÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
ѰÕÒÖеÄÈ˲Å7Â¥
2012-11-05 19:03
»Ø¸´
ÈýÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
ysmzhy8Â¥
2012-11-09 08:56
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xiaolouluo9Â¥
2012-11-12 09:25
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
yeahdc10Â¥
2012-11-22 00:00
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
¾²Ñ¾11Â¥
2012-11-23 21:35
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí
geminglao12Â¥
2012-11-26 16:49
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
bingling340813Â¥
2012-11-29 14:00
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
pch196714Â¥
2012-12-03 07:22
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡













»Ø¸´´ËÂ¥
ÆÕͨli
50